Catalyst Wire Dossier Catalyst Wire Dossier

Autologous stromal-vascular fraction of adipose tissue cells

· Swiss Medica XXI Century S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous stromal-vascular fraction of adipose tissue cells, covering 2019-08-08 to 2019-08-08. Get the full timeline:

Most recent: Clinical Trial Update: The Evaluation of Safety and Effectiveness of Intraarticular Administration of Autologous Stromal-Vascular Fraction of Adipose Tissue Cells for Treatment of Knee Joint Arthrosis [Phase 2]

See pricing